Skip to content

VERAXA Biotech (VERX) via Voyager Acq (VACH) deck

VERAXA Biotech discovers and develops next-generation antibody-based therapeutics powered by transformative technologies and pioneering research from EMBL.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest